The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds have the general formula I:
wherein X, Y, A, R
1
, R
2
, R
3
, R
4
, R
4
′, R
5
, R
5
′, R
6
and R
6
′ are as described herein.
The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds have the general formula I:
wherein X, Y, A, R
1
, R
2
, R
3
, R
4
, R
4
′, R
5
, R
5
′, R
6
and R
6
′ are as described herein.